INTERNATIONAL DESK: Biopharmaceutical major Biocon NSE -0.77 % has its eyes set on the US insulin market, which is expected…
Browsing: $30b
INTERNATIONAL DESK: Biopharmaceutical major Biocon NSE -0.77 % has its eyes set on the US insulin market, which is expected…